The U.S. Food and Drug Administration (FDA) announced that it has approved Ultresa™ delayed-release capsules, a pancreatic enzyme replacement therapy. Ultresa (pancrelipase) is manufactured by Aptalis Pharma.
Site Search
Showing 61 - 64 of 64 results
News
|
|
3 min read
News
|
|
3 min read
News
|
|
1 min read
News
|
|
1 min read